BiotechTube
Home/Vesteck/Joseph W. Rafferty
JW

Joseph W. Rafferty

CEO

Vesteck

Therapeutic Areas

Vascular SurgeryAortic Aneurysm

Vesteck Pipeline

DrugIndicationPhase
Suture-Tight™ Endovascular Suturing SystemAugmentation of endograft fixation in Abdominal Aortic Aneurysm (AAA) repairPivotal Trial Preparation

Leadership Team at Vesteck

KS
Kent Stalker
COO, VP R&D
TW
Ted Wulfman
CTO
TH
Terrie Heidemann
Senior Director, Regulatory Affairs and Quality Assurance
DJ
Dr. John Edoga
Founder, General Surgeon
DT
Dr. Thierry Richard
Founder, CT Surgeon
View full Vesteck profile